CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $910,000 | +21.0% | 197,300 | -12.4% | 0.00% | 0.0% |
| Q4 2020 | $752,000 | +10.3% | 225,280 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $682,000 | -35.5% | 229,480 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $1,057,000 | +21.9% | 228,872 | +1.6% | 0.00% | 0.0% |
| Q1 2020 | $867,000 | +13.3% | 225,229 | +10.3% | 0.00% | 0.0% |
| Q4 2019 | $765,000 | +5.7% | 204,129 | +49.8% | 0.00% | 0.0% |
| Q3 2019 | $724,000 | +186.2% | 136,253 | +106.8% | 0.00% | – |
| Q2 2019 | $253,000 | +25.2% | 65,895 | +66.7% | 0.00% | – |
| Q1 2019 | $202,000 | +85.3% | 39,532 | -30.3% | 0.00% | – |
| Q4 2018 | $109,000 | -49.1% | 56,700 | 0.0% | 0.00% | – |
| Q3 2018 | $214,000 | +65.9% | 56,700 | +37.2% | 0.00% | – |
| Q2 2018 | $129,000 | +30.3% | 41,332 | 0.0% | 0.00% | – |
| Q1 2018 | $99,000 | -38.9% | 41,332 | 0.0% | 0.00% | – |
| Q4 2017 | $162,000 | +55.8% | 41,332 | 0.0% | 0.00% | – |
| Q3 2017 | $104,000 | -8.8% | 41,332 | 0.0% | 0.00% | – |
| Q2 2017 | $114,000 | +40.7% | 41,332 | 0.0% | 0.00% | – |
| Q1 2017 | $81,000 | +88.4% | 41,332 | 0.0% | 0.00% | – |
| Q4 2016 | $43,000 | -4.4% | 41,332 | 0.0% | 0.00% | – |
| Q3 2016 | $45,000 | +55.2% | 41,332 | 0.0% | 0.00% | – |
| Q2 2016 | $29,000 | -39.6% | 41,332 | 0.0% | 0.00% | – |
| Q1 2016 | $48,000 | -52.5% | 41,332 | 0.0% | 0.00% | – |
| Q4 2015 | $101,000 | -18.5% | 41,332 | 0.0% | 0.00% | – |
| Q3 2015 | $124,000 | -27.5% | 41,332 | 0.0% | 0.00% | – |
| Q2 2015 | $171,000 | +23.9% | 41,332 | 0.0% | 0.00% | – |
| Q1 2015 | $138,000 | 0.0% | 41,332 | 0.0% | 0.00% | – |
| Q4 2014 | $138,000 | +0.7% | 41,332 | 0.0% | 0.00% | – |
| Q3 2014 | $137,000 | +30.5% | 41,332 | 0.0% | 0.00% | – |
| Q2 2014 | $105,000 | +15.4% | 41,332 | 0.0% | 0.00% | – |
| Q1 2014 | $91,000 | 0.0% | 41,332 | 0.0% | 0.00% | – |
| Q4 2013 | $91,000 | -27.8% | 41,332 | 0.0% | 0.00% | – |
| Q3 2013 | $126,000 | +240.5% | 41,332 | 0.0% | 0.00% | – |
| Q2 2013 | $37,000 | – | 41,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |